Trial Profile
A prospective study assessing hepatic fibrosis after direct acting antiviral therapy (Sofosbuvir, simeprevir, ribavirin) in patients with HCV recurrence post liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2017
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 17 Nov 2017 New trial record
- 27 Sep 2017 Results presented at the 18th Congress of the European Society for Organ Transplantation